NYSE · CLX

Clorox Company

$97.41 +$1.86 (+1.95%) 1D After hours

Key Metrics

$11.55B
Market cap
15.28×
P/E · TTM
$6.76B
Revenue · TTM
$756.00M
Net income
EPS · TTM $6.18
Dividend yield 5.2%
Free cash flow $380.00M
Beta · 1Y 0.17
EBITDA · TTM $1.10B
Gross margin 43.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 5
    From its Feb 27 high, the share price fell 32%.

    Peak close $127.16 on Feb 27; trough close $86.12 on May 5. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -32%
  • May 1
    The stock moved -9.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 1

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$11.55B
Enterprise value$14.45B
Shares outstanding120.9M
52-wk range$84.70 – $128.90
Avg volume · 20D1.5M
Net cash −$2.89B
Book value / share$-0.55
IndustrySpecialty Cleaning, Polishing And Sanitation Preparations
ExchangeNYSE
About Clorox Company
IPO dateJun 1, 1972
Employees7600

Since its inception more than 100 years ago, Clorox has expanded to operate in a variety of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal care products.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E15.28
P/S1.71
P/FCF30.41
EV/EBITDA13.10
EV/Sales2.14
Graham №

Profitability

Gross 43.8%
Operating 14.6%
Net 11.2%
FCF 5.6%
ROE / ROIC 579.3% · 27.3%

Financial Health

Current ratio0.84
Quick ratio0.65
Debt / equity-60.87
Debt / EBITDA 3.70
Net cash −$2.89B
Working capital−$504.00M

Cash Flow · TTM

Operating CF $576.00M
Capex −$196.00M
Free cash flow $380.00M
Buybacks $331.00M
Dividends paid $602.00M
Shareholder yield 8.1%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

2.6
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings